Article Sidebar

PDF
Date Published: 30/03/2023
Abstract Views: 229
Views PDF: 131
DOI: https://doi.org/10.51298/vmj.v524i2.4816
Issue
Vol. 524 No. 2 (2023)
Section
Các bài báo
How to Cite
Đỗ , H. K. ., & Trần , T. H. . (2023). EVALUATING THE SURVIVAL OUTCOME OF PATIETNS DIAGNOSED OF P16-POSITIVE OROPHARYNGEAL CANCER AT NATIONAL CANCER HOSPITAL. Vietnam Medical Journal, 524(2). https://doi.org/10.51298/vmj.v524i2.4816

EVALUATING THE SURVIVAL OUTCOME OF PATIETNS DIAGNOSED OF P16-POSITIVE OROPHARYNGEAL CANCER AT NATIONAL CANCER HOSPITAL

Hùng Kiên Đỗ 1,, Thị Hậu Trần 2
1 K hospital
2 k hospital

Main Article Content

Abstract

Objective: Evaluating the survival outcomes and analyzing the prognostic factors of patients diagnosed of p16-positive oropharyngeal cancer at National Cancer Hospital from 09/2017 to 09/2022. Patients and method: Retrospective and prospective analysis of 33 patients with p16-positive oropharyngeal cancer were diagnosed and treated at National Cancer Hospital from 09/2017 to 09/2022. Results: The 3-year and 5-year overall survival (OS) rates were 78.2% and 76.1%, respectively. Patients with stages I-II had higher 5-year OS rate than patients with stages III-IV (86,2% vs 67.9%), there was a significant difference with p=0.044. Patients with ECOG 0-1 had higher 5-year OS rate than patients with ECOG 2-3 (82.3% vs 66.8%), there was a significant difference with p=0.043. Age, sex and histological grade did not influence the 5-year OS rate. Conclusion: P16-positive oropharyngeal squamous cell cancer patient have good prognosis with the 5-year OS rate of 76.1%. Disease stage and ECOG influenced overall survival.

Article Details

Keywords

Oropharyngeal cancer, p16 positive, overall survival.

References

1. Gillison, M.L.; D’Souza, G.; Westra, W.; Sugar, E.; Xiao, W.; Begum, S.; Viscidi, R. Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers. J. Natl. Cancer Inst. 2008, 100, 407–420, doi:10.1093/jnci/djn025.
2. Maria Isabel Tovar Martín; Miguel Juan Martínez Carrillo; Rosario Guerrero Tejada Human Papillomavirus Detection in Head and Neck Squamous Cell Carcinomas and Its Clinical Implications. In Histopathology; Enrique Poblet Martinez, Ed.; IntechOpen: Rijeka, 2012; p. Ch. 1.
3. Ragin, C.C.R.; Taioli, E. Survival of Squamous Cell Carcinoma of the Head and Neck in Relation to Human Papillomavirus Infection: Review and Meta-Analysis. Int. J. Cancer 2007, 121, 1813–1820, doi:10.1002/ijc.22851.
4. Albers, A.E.; Qian, X.; Kaufmann, A.M.; Coordes, A. Meta Analysis: HPV and P16 Pattern Determines Survival in Patients with HNSCC and Identifies Potential New Biologic Subtype. Sci. Rep. 2017, 7, 16715, doi:10.1038/s41598-017-16918-w.
5. Heiduschka, G.; Grah, A.; Oberndorfer, F.; Kadletz, L.; Altorjai, G.; Kornek, G.; Wrba, F.; Thurnher, D.; Selzer, E. Improved Survival in HPV/P16-Positive Oropharyngeal Cancer Patients Treated with Postoperative Radiotherapy. Strahlenther. Onkol. 2015, 191, 209–216, doi:10.1007/s00066-014-0753-7.
6. Lee, J.; Chang, J.S.; Kwon, H.J.; Kim, S.-H.; Shin, S.J.; Keum, K.C. Impact of P16 Expression in Oropharyngeal Cancer in the Postoperative Setting: The Necessity of Re-Evaluating Traditional Risk Stratification. Jpn. J. Clin. Oncol. 2016, 46, 911–918, doi:10.1093/jjco/hyw099.
7. Haughey, B.H.; Sinha, P. Prognostic Factors and Survival Unique to Surgically Treated P16+ Oropharyngeal Cancer. The Laryngoscope 2012, 122 Suppl 2, S13-33, doi:10.1002/lary.23493.
8. Rahmati, R.; Dogan, S.; Pyke, O.; Palmer, F.; Awad, M.; Lee, N.; Kraus, D.H.; Shah, J.P.; Patel, S.G.; Ganly, I. Squamous Cell Carcinoma of the Tonsil Managed by Conventional Surgery and Postoperative Radiation. Head Neck 2015, 37, 800–807, doi:10.1002/hed.23679.
9. Gorphe, P.; Classe, M.; Ammari, S.; Garcia, G.; Even, C.; Casiraghi, O.; Breuskin, I.; Tao, Y.; Temam, S.; Blanchard, P.; et al. Patterns of Disease Events and Causes of Death in Patients with HPV-Positive versus HPV-Negative Oropharyngeal Carcinoma. Radiother. Oncol. 2022, 168, 40–45, doi:10.1016/j.radonc.2022.01.021.
10. Ang, K.K.; Harris, J.; Wheeler, R.; Weber, R.; Rosenthal, D.I.; Nguyen-Tân, P.F.; Westra, W.H.; Chung, C.H.; Jordan, R.C.; Lu, C.; et al. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer. N. Engl. J. Med. 2010, 363, 24–35, doi:10.1056/NEJMoa0912217.